The Canadian Integrated Program for Antimicrobial Resistance Surveillance (CIPARS) Annual Stakeholder Meeting Integrated Findings Presentation

Earlier this week, the Canadian Integrated Program for Resistance Surveillance (CIPARS) held their annual stakeholder meeting to discuss key findings from the 2018 calendar year on how antimicrobial medications are being utilized across the country.


Some highlights in the presentation on antimicrobial use and resistance include:

  • An increase in sales from 2017 to 2018 (by 5%)
  • An overall reduction of antimicrobial use in broiler chickens (with some provincial variation)
  • A decrease in antimicrobial use in pigs
  • An increase overall in antimicrobial use in turkeys
  • Of the antimicrobials sold in Canada, 78% of them were for use in food-producing animals, 21% were intended for human use, and 2% were for crops and companion animals

With respect to antimicrobial resistance, the largest number of Salmonella isolates across human, animal and food sources was found within the 2018 calendar year.


The presentation also highlights the work being done by the poultry industry to reduce their use of Category I antimicrobials.


View the full presentation here: CIPARS_2018_Integrated_Results_EN